Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. (Q34156748)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. |
scientific article |
Statements
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors (English)
Kenneth C Anderson
Tuna Mutis
Michel de Weers
Yu-Tzu Tai
Michael S van der Veer
Joost M Bakker
Tom Vink
Daniëlle C H Jacobs
Lukas A Oomen
Matthias Peipp
Thomas Valerius
Jerry W Slootstra
Wim K Bleeker
Jan G J van de Winkel
27 December 2010